Arbuckle Stuart A bought RYTM
June 23, 2026 · Form 4 insider transaction
Arbuckle Stuart A bought 4,712 shares of Rhythm Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,712
Price
N/A
Total value
N/A
InsiderArbuckle Stuart A
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 23, 2026
Filing dateJune 25, 2026
Shares owned after11,712
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.